217 related articles for article (PubMed ID: 29475932)
1. Differences in Urinary Amino Acid Patterns in Individuals with Different Types of Urological Tumor Urinary Amino Acid Patterns as Markers of Urological Tumors.
Duskova K; Vesely S; DO Carmo Silva J; Cernei N; Zitka O; Heger Z; Adam V; Havlova K; Babjuk M
In Vivo; 2018; 32(2):425-429. PubMed ID: 29475932
[TBL] [Abstract][Full Text] [Related]
2. Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
Mlcochova H; Hezova R; Stanik M; Slaby O
Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473
[TBL] [Abstract][Full Text] [Related]
3. [Molecular diagnostics in urologic oncology. Detection of nucleic acids in urine samples].
Müller M; Goessl C; Krause H; Miller K
Urologe A; 2003 May; 42(5):660-8. PubMed ID: 12750801
[TBL] [Abstract][Full Text] [Related]
4. [The clinical usefulness of urinary basic fetoprotein (BFP) in patients with urological malignancies].
Tsujii T; Yonese J; Kojima S; Tari K; Ishii M; Seino Y
Nihon Hinyokika Gakkai Zasshi; 1990 Jun; 81(6):829-34. PubMed ID: 1698231
[TBL] [Abstract][Full Text] [Related]
5. [Significance of current bio- and molecular-markers in urological cancers].
Shimazui T; Akaza H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1008-14. PubMed ID: 15272577
[TBL] [Abstract][Full Text] [Related]
6. Role of coagulation factors in urological malignancy: A prospective, controlled study on prostate, renal and bladder cancer.
Alevizopoulos A; Tyritzis S; Leotsakos I; Anastasopoulou I; Pournaras C; Kotsis P; Katsarou O; Alamanis C; Stravodimos K; Constantinides C
Int J Urol; 2017 Feb; 24(2):130-136. PubMed ID: 28004432
[TBL] [Abstract][Full Text] [Related]
7. [Tumor markers in urological malignancies].
Kuriyama M
Nihon Rinsho; 1996 Jun; 54(6):1631-6. PubMed ID: 8691621
[TBL] [Abstract][Full Text] [Related]
8. Validation study of urinary metabolites as potential biomarkers for prostate cancer detection.
Gamagedara S; Kaczmarek AT; Jiang Y; Cheng X; Rupasinghe M; Ma Y
Bioanalysis; 2012 Jun; 4(10):1175-83. PubMed ID: 22651561
[TBL] [Abstract][Full Text] [Related]
9. Proteomic studies in urological malignancies.
Ferguson RE; Selby PJ; Banks RE
Contrib Nephrol; 2004; 141():257-79. PubMed ID: 14650238
[No Abstract] [Full Text] [Related]
10. Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis.
Iwaki H; Kageyama S; Isono T; Wakabayashi Y; Okada Y; Yoshimura K; Terai A; Arai Y; Iwamura H; Kawakita M; Yoshiki T
Cancer Sci; 2004 Dec; 95(12):955-61. PubMed ID: 15596044
[TBL] [Abstract][Full Text] [Related]
11. [Urine polyamine in patients with malignant urological diseases using a polyamine-test enzyme kit].
Sakai S; Koide T; Ito Y; Tei K; Deguchi T; Matsuda S; Kato N; Ban Y; Nishiura T
Hinyokika Kiyo; 1986 May; 32(5):661-5. PubMed ID: 3751793
[TBL] [Abstract][Full Text] [Related]
12. Tumor M2 pyruvate kinase in plasma of patients with urological tumors.
Roigas J; Schulze G; Raytarowski S; Jung K; Schnorr D; Loening SA
Tumour Biol; 2001; 22(5):282-5. PubMed ID: 11553857
[TBL] [Abstract][Full Text] [Related]
13. Urinary amino acid excretion: comparison of normal individuals and patients with bladder cancer.
McGregor RF; Crawford R; Johnson DE; Brown B; Sharon MS; Johnston D
Urology; 1977 May; 9(5):538-42. PubMed ID: 871045
[TBL] [Abstract][Full Text] [Related]
14. Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies.
Ellinger J; Müller DC; Müller SC; Hauser S; Heukamp LC; von Ruecker A; Bastian PJ; Walgenbach-Brunagel G
Urol Oncol; 2012; 30(4):509-15. PubMed ID: 20870429
[TBL] [Abstract][Full Text] [Related]
15. Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancers.
Wood SL; Knowles MA; Thompson D; Selby PJ; Banks RE
Nat Rev Urol; 2013 Apr; 10(4):206-18. PubMed ID: 23443013
[TBL] [Abstract][Full Text] [Related]
16. Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers.
Lin SY; Linehan JA; Wilson TG; Hoon DSB
Eur Urol Focus; 2017 Apr; 3(2-3):265-272. PubMed ID: 28753876
[TBL] [Abstract][Full Text] [Related]
17. [Urologic tumors in old age].
Debruyne FM
Tijdschr Gerontol Geriatr; 1986 Apr; 17(2):65-8. PubMed ID: 3715964
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune disease and subsequent urological cancer.
Liu X; Ji J; Forsti A; Sundquist K; Sundquist J; Hemminki K
J Urol; 2013 Jun; 189(6):2262-8. PubMed ID: 23228387
[TBL] [Abstract][Full Text] [Related]
19. Determination of amino acids in urine of patients with prostate cancer and benign prostate growth.
Sroka WD; Boughton BA; Reddy P; Roessner U; Słupski P; Jarzemski P; Dąbrowska A; Markuszewski MJ; Marszałł MP
Eur J Cancer Prev; 2017 Mar; 26(2):131-134. PubMed ID: 27222937
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--NMP22 as a urinary marker for surveillance of bladder cancer. NMP22 Study Group].
Akaza H; Miyanaga N; Tsukamoto T; Ishikawa S; Noguchi R; Ohtani M; Kawabe K; Kubota Y; Fujita K; Obata K; Hirao Y; Kotake T; Ohmori H; Kumazawa J; Koiso K
Gan To Kagaku Ryoho; 1997 May; 24(7):829-36. PubMed ID: 9170521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]